Clinical trials, drug development and research news
Tag
Patient GuidesSome treatments cannot be disguised. This guide explains open-label trials, the biases they risk and how to judge them, using the LATE-MT stroke and SINGLE-AF trials.
30 October 2026
Patient GuidesA 69% risk cut can mean a handful of people. This guide shows how to read absolute risk, NNT, confidence intervals and p-values using a real 2026 trial.
20 October 2026
CardiologyThe SINGLE-AF trial found apixaban or rivaroxaban cut serious events from 1.5% to 0.5% in AF patients at intermediate stroke risk, without more major bleeding.
28 August 2026